A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer

  • Jeyalakshmi Kandhavelu
  • , Kumar Subramanian
  • , Vivash Naidoo
  • , Giulia Sebastianelli
  • , Phuong Doan
  • , Saravanan Konda Mani
  • , Hande Yapislar
  • , Ebru Haciosmanoglu
  • , Leman Arslan
  • , Samed Ozer
  • , Ramesh Thiyagarajan
  • , Nuno R. Candeias
  • , Clement Penny
  • , Meenakshisundaram Kandhavelu
  • , Akshaya Murugesan

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science